Search alternatives:
sizes decrease » size increase (Expand Search), scores decreased (Expand Search)
gap decreased » gain decreased (Expand Search), a decreased (Expand Search), gy decreased (Expand Search)
i.e decrease » we decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
Showing 1 - 20 results of 9,505 for search '(( significant ((i.e decrease) OR (sizes decrease)) ) OR ( significant gap decreased ))', query time: 0.56s Refine Results
  1. 1
    Overexpression of Gαq decreases cell number and cell size.

    Overexpression of Gαq decreases cell number and cell size. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    “…Overexpression of Gαq in the pouch results in a decrease in total wing area, cell number and cell size. 10 samples were analyzed per condition. …”
    Save to List
    Saved in:
  2. 2
    Gap junction (GJ) communication decreases the proportion of cells exhibiting Ca<sup>2+</sup> spikes.

    Gap junction (GJ) communication decreases the proportion of cells exhibiting Ca<sup>2+</sup> spikes. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    Save to List
    Saved in:
  3. 3
    Words for describing activities that decrease and/or increase Subjective Well-Being.

    Words for describing activities that decrease and/or increase Subjective Well-Being. by August Håkan Nilsson (12937056)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 4
    <i>SOX2</i> knockdown decreases OSCC cell migration and EMT.

    <i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

    Published 2023
    Save to List
    Saved in:
  5. 5
    Increasing gaps and decreasing returns attenuate spending effects.

    Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

    Published 2024
    Save to List
    Saved in:
  6. 6
    GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).

    GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

    Published 2022
    “…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”
    Save to List
    Saved in:
  7. 7
    Higher reward decreases three measures of response variability.

    Higher reward decreases three measures of response variability. by Zvi N. Roth (9611598)

    Published 2020
    Save to List
    Saved in:
  8. 8
    Co dopant Concentration vs. average crystallite size.

    Co dopant Concentration vs. average crystallite size. by Adil Muhammad (13003230)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 9
    H2: MP<sub>t-2</sub> x profit decreased.

    H2: MP<sub>t-2</sub> x profit decreased. by Marie Finnegan (10036657)

    Published 2024
    Save to List
    Saved in:
  10. 10
    Species richness decreases significantly with increasing percent disturbance.

    Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

    Published 2019
    Save to List
    Saved in:
  11. 11
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 12
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 13
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 14
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 15
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 16
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 17
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 18
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 19
    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy.

    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

    Published 2021
    Save to List
    Saved in:
  20. 20
    Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen.

    Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

    Published 2023
    “…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”
    Save to List
    Saved in:

Search Tools: